Table 2.
Flare counts (ph/ms) | ICGA scores | SFCT (μm) | Iridocyclitis | SRD | ||
---|---|---|---|---|---|---|
CVKH2 | R | <10 | 4 | <280 | − | − |
L | <10 | <4 | 327 | − | − | |
| ||||||
CVKH3 | R | 11.6 | 8 | <280 | − | − |
L | 18 | 10 | <280 | − | − | |
| ||||||
CVKH4 | R | 23.1 | 8 | <280 | − | − |
L | 10.2 | 10 | <280 | − | − | |
| ||||||
CVKH5 | R | 14.1 | 16 | <280 | − | − |
L | 12.8 | 18 | <280 | − | − | |
| ||||||
CVKH6 | R | <10 | <4 | <280 | − | − |
L | <10 | <4 | <280 | − | − | |
| ||||||
CVKH7 | R | 22.4 | 14 | <280 | − | − |
L | 12.4 | 12 | 288 | − | − | |
| ||||||
CVKH9 | R | 11.1 | 8 | <280 | − | − |
L | <10 | 10 | <280 | − | − | |
| ||||||
CVKH10 | R | 14.6 | 21 | <280 | + | + |
L | 18.6 | <4 | <280 | + | − | |
| ||||||
CVKH11 | R | 23.3 | 10 | <280 | + | − |
L | 23.8 | 11 | <280 | − | − | |
| ||||||
CVKH13 | R | 15.8 | 6 | <280 | − | − |
L | 30.2 | 4 | <280 | − | − | |
| ||||||
CVKH14 | R | <10 | 14 | 351 | − | − |
L | <10 | 16 | 380 | − | − | |
| ||||||
CVKH15 | R | <10 | 10 | 368 | − | − |
L | <10 | 10 | 361 | − | − | |
| ||||||
CVKH16 | R | 19.6 | 8 | 360 | − | − |
L | 16.5 | 5 | 345 | + | − | |
| ||||||
CVKH17 | R | 12.4 | 5 | <280 | − | − |
L | 16.4 | 6 | <280 | − | − | |
| ||||||
CVKH18 | R | <10 | <4 | 334 | − | − |
L | <10 | <4 | 283 | − | − | |
| ||||||
CVKH19 | R | 38.6 | <4 | <280 | − | − |
L | 32.5 | 4 | <280 | − | − | |
| ||||||
CVKH20 | R | 13.7 | 8 | <280 | − | − |
L | 15.3 | 4 | <280 | − | − |
ICGA, indocyanine green angiography; SFCT, subfoveal choroidal thickness; AI, clinical anterior inflammation; SRD, serous retinal detachment.